Nebula Research & Development LLC Allogene Therapeutics, Inc. Transaction History

Nebula Research & Development LLC

  • $618 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$2.92 - $5.63 $69,931 - $134,832
-23,949 Reduced 17.11%
115,988 $518 Million
Q4 2023

Feb 14, 2024
BUY
$2.28 - $3.5 $319,056 - $489,779
139,937 New
139,937 $449 Million
Q2 2023

Aug 14, 2023
BUY
$4.53 - $6.74 $121,857 - $181,306
26,900 New
26,900 $134 Million

Others Institutions Holding ALLO

# of Institutions
176
Shares Held
132M
Call Options Held
94.3K
Put Options Held
112K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $418M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email